Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience
β Scribed by Natale Cascinelli; Filiberto Belli; Mario Santinami; Vuk Fait; Alessandro Testori; W. Ruka; Renato Cavaliere; Nicola Mozzillo; Carlo Riccardo Rossi; Rona M. MacKie; Omgo Nieweg; Marcello Pace; K. Kirov
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 128 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The role of elective lymph node dissection (ELND) for treatment of cutaneous melanoma is still debated. Initially, lymphatic mapping technique was performed by an intradermic injection of vital blue dye; subsequently, it was improved by the use of radioguided surgery (RGS). Preliminary experience wi
## Abstract ## Background Sentinel lymph node biopsy (SNB) is a widely adopted staging procedure in patients with cutaneous melanoma. The benefits of SNB have not been evaluated thoroughly in older age groups. ## Methods This was a two-centre retrospective observational study of patients with me
## Abstract ## Background Current therapy for intermediate thickness melanoma involves wide local excision with sentinel lymph node biopsy (SLNB). SLNB provides important prognostic information and immediate regional lymphadenectomy for a positive sentinel lymph node (SLN) may improve survival and